Gilead Sciences, Inc.
GILD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $115,185 | $101,100 | $107,742 | $91,198 |
| - Cash | $9,991 | $6,085 | $5,412 | $5,338 |
| + Debt | $26,711 | $24,987 | $25,230 | $26,695 |
| Enterprise Value | $131,905 | $120,002 | $127,560 | $112,555 |
| Revenue | $28,754 | $27,116 | $27,281 | $27,305 |
| % Growth | 6% | -0.6% | -0.1% | – |
| Gross Profit | $22,503 | $20,618 | $21,624 | $20,704 |
| % Margin | 78.3% | 76% | 79.3% | 75.8% |
| EBITDA | $4,434 | $10,496 | $8,852 | $11,329 |
| % Margin | 15.4% | 38.7% | 32.4% | 41.5% |
| Net Income | $480 | $5,665 | $4,592 | $6,225 |
| % Margin | 1.7% | 20.9% | 16.8% | 22.8% |
| EPS Diluted | 0.38 | 4.5 | 3.64 | 4.93 |
| % Growth | -91.6% | 23.6% | -26.2% | – |
| Operating Cash Flow | $10,828 | $8,006 | $9,072 | $11,384 |
| Capital Expenditures | -$523 | -$585 | -$728 | -$579 |
| Free Cash Flow | $10,305 | $7,421 | $8,344 | $10,805 |